• EI
  • Scopus
  • 中国科技期刊卓越行动计划项目资助期刊
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国精品科技期刊
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国科技核心期刊CSTPCD
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
赵文婷,陈智仙,张海波. 鼠李糖乳杆菌和乳双歧杆菌的复合益生菌粉对小鼠免疫功能的影响及其食用安全性的研究[J]. 华体会体育,2022,43(18):380−389. doi: 10.13386/j.issn1002-0306.2021120087.
引用本文: 赵文婷,陈智仙,张海波. 鼠李糖乳杆菌和乳双歧杆菌的复合益生菌粉对小鼠免疫功能的影响及其食用安全性的研究[J]. 华体会体育,2022,43(18):380−389. doi: 10.13386/j.issn1002-0306.2021120087.
ZHAO Wenting, CHEN Zhixian, ZHANG Haibo. Effect of Compound Probiotic Powder of Lactobacillus rhamnosus and Bifidobacterium lactis on the Immune Function of Mice and Its Edible Safety[J]. Science and Technology of Food Industry, 2022, 43(18): 380−389. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021120087.
Citation: ZHAO Wenting, CHEN Zhixian, ZHANG Haibo. Effect of Compound Probiotic Powder of Lactobacillus rhamnosus and Bifidobacterium lactis on the Immune Function of Mice and Its Edible Safety[J]. Science and Technology of Food Industry, 2022, 43(18): 380−389. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021120087.

鼠李糖乳杆菌和乳双歧杆菌的复合益生菌粉对小鼠免疫功能的影响及其食用安全性的研究

Effect of Compound Probiotic Powder of Lactobacillus rhamnosus and Bifidobacterium lactis on the Immune Function of Mice and Its Edible Safety

  • 摘要: 为研究鼠李糖乳杆菌和乳双歧杆菌的复合益生菌粉对小鼠免疫力的影响及其食用安全性。该研究分别将低、中、高剂量(1.00、0.67、0.34 g/kg BW)以及溶剂对照组(蒸馏水)的复合益生菌粉每天经口灌胃给小鼠,连续30 d,观测脏器/体重比值、细胞免疫功能、体液免疫功能、单核-巨噬细胞功能、NK细胞活性等指标,以此评价复合益生菌粉对小鼠免疫功能的影响。此外,采用大鼠急性毒性试验、遗传毒性试验(小鼠骨髓细胞微核试验、小鼠精子畸形试验、Ames试验)和大鼠30 d喂养试验进行食用安全性研究。结果表明,与阴性对照组相比,高剂量组小鼠迟发型变态反应(DTH)、抗体细胞生成(PFC)、血清溶血素水平、小鼠碳廓清吞噬指数等指标均有显著提升(P<0.05),中剂量组小鼠碳廓清吞噬指数也有显著提升(P<0.05),但低剂量组并未表现出明显差异。此外,小鼠骨髓细胞微核试验、小鼠精子畸形试验、Ames试验三项结果均为阴性;大鼠30 d喂养试验中,试验剂量在0.84~3.34 g/kg BW范围内,大鼠的生长发育良好,各指标与溶剂对照组比较,均无显著性差异(P>0.05)。所以,鼠李糖乳杆菌和乳双歧杆菌复合益生菌粉能够增强小鼠免疫力且无急性毒性、遗传毒性和亚急性毒性,具有较高的食用安全性。

     

    Abstract: In order to explore the effect of the compound probiotic powder of Lactobacillus rhamnosus and Bifidobacterium lactis on the immunity of mice and its food safety. In this study, low, medium and high doses (1.00, 0.67, 0.34g/kg BW) of compound probiotic powder were orally administered to mice to observe the organ/weight ratio, cellular immune function, humoral immune function, monocyte-macrophage function, NK cell activity and other indicators, comprehensively evaluate the effect of compound probiotic powder on the immune function of mice for 30 d. In addition, rat acute toxicity test, genetic toxicity test (mouse bone marrow cell micronucleus test, mouse sperm deformity test, Ames test) and 30-day feeding test for rats were used for food safety research. The results showed that, compared with the negative control group, the high-dose group mice had significantly increased delayed-type hypersensitivity (DTH), antibody cell production (PFC), serum hemolysin levels, and the phagocytosis index of carbon clearance in mice (P<0.05), the carbon clearance and phagocytosis index of mice in the middle-dose group also increased significantly(P<0.05), but the low-dose group did not show a significant difference. In addition, the results of the mouse bone marrow cell micronucleus test, the mouse sperm abnormality test, and the Ames test were all negative. In the rat feeding test for 30 days, the test dose was in the range of 0.84~3.34 g/kg BW, and the growth of the rat was well developed, there was no significant difference in each index compared with the solvent control group (P>0.05). The growth and development of rats were good, and there was no significant difference in each index compared with the solvent control group (P>0.05). Therefore, the compound probiotic powder of Lactobacillus rhamnosus and Bifidobacterium lactis could enhance immunity without acute toxicity, genetic toxicity and subacute toxicity, and had high edible safety.

     

/

返回文章
返回